Pathogenesis of depression: insights from human and rodent studies
Major depressive disorder (MDD) will affect one out of every five people in their lifetime and
is the leading cause of disability worldwide. Nevertheless, mechanisms associated with the …
is the leading cause of disability worldwide. Nevertheless, mechanisms associated with the …
WNT signaling in cardiac and vascular disease
WNT signaling is an elaborate and complex collection of signal transduction pathways
mediated by multiple signaling molecules. WNT signaling is critically important for …
mediated by multiple signaling molecules. WNT signaling is critically important for …
GSK-3β, a pivotal kinase in Alzheimer disease
Alzheimer disease (AD) is the most common form of age-related dementia. The etiology of
AD is considered to be multifactorial as only a negligible percentage of cases have a familial …
AD is considered to be multifactorial as only a negligible percentage of cases have a familial …
Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics
Deciphering what governs inflammation and its effects on tissues is vital for understanding
many pathologies. The recent discovery that glycogen synthase kinase-3 (GSK3) promotes …
many pathologies. The recent discovery that glycogen synthase kinase-3 (GSK3) promotes …
LTP inhibits LTD in the hippocampus via regulation of GSK3β
Summary Glycogen synthase kinase-3 (GSK3) has been implicated in major neurological
disorders, but its role in normal neuronal function is largely unknown. Here we show that …
disorders, but its role in normal neuronal function is largely unknown. Here we show that …
Glycogen synthase kinase-3 inhibitors: preclinical and clinical focus on CNS-A decade onward
The protein kinase, GSK-3, participates in diverse biological processes and is now
recognized a promising drug discovery target in treating multiple pathological conditions …
recognized a promising drug discovery target in treating multiple pathological conditions …
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder
The mood stabilizers lithium and valproic acid (VPA) are traditionally used to treat bipolar
disorder (BD), a severe mental illness arising from complex interactions between genes and …
disorder (BD), a severe mental illness arising from complex interactions between genes and …
Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application
MJ Millan - Pharmacology & therapeutics, 2006 - Elsevier
Major depression is a debilitating and recurrent disorder with a substantial lifetime risk and a
high social cost. Depressed patients generally display co-morbid symptoms, and depression …
high social cost. Depressed patients generally display co-morbid symptoms, and depression …
GSK-3 inhibitors: preclinical and clinical focus on CNS
Inhibiting glycogen synthase kinase-3 (GSK-3) activity via pharmacological intervention has
become an important strategy for treating neurodegenerative and psychiatric disorders. The …
become an important strategy for treating neurodegenerative and psychiatric disorders. The …
Lithium and therapeutic targeting of GSK-3
Lithium salts have been in the therapeutic toolbox for better or worse since the 19th century,
with purported benefit in gout, hangover, insomnia, and early suggestions that lithium …
with purported benefit in gout, hangover, insomnia, and early suggestions that lithium …